ATE310000T1 - Ein thiazolidindionderivat und seine verwendung als antidiabetikum - Google Patents

Ein thiazolidindionderivat und seine verwendung als antidiabetikum

Info

Publication number
ATE310000T1
ATE310000T1 AT01963256T AT01963256T ATE310000T1 AT E310000 T1 ATE310000 T1 AT E310000T1 AT 01963256 T AT01963256 T AT 01963256T AT 01963256 T AT01963256 T AT 01963256T AT E310000 T1 ATE310000 T1 AT E310000T1
Authority
AT
Austria
Prior art keywords
compound
antidiabetic drug
thiazolidinedione derivative
thiazolidinedione
derivative
Prior art date
Application number
AT01963256T
Other languages
English (en)
Inventor
Andrew Simon Craig
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE310000T1 publication Critical patent/ATE310000T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01963256T 2000-09-05 2001-09-05 Ein thiazolidindionderivat und seine verwendung als antidiabetikum ATE310000T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021784.4A GB0021784D0 (en) 2000-09-05 2000-09-05 Novel pharmaceutical
PCT/GB2001/003996 WO2002020520A1 (en) 2000-09-05 2001-09-05 A thiazolidinedione derivative and its use as antidiabetic

Publications (1)

Publication Number Publication Date
ATE310000T1 true ATE310000T1 (de) 2005-12-15

Family

ID=9898884

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01963256T ATE310000T1 (de) 2000-09-05 2001-09-05 Ein thiazolidindionderivat und seine verwendung als antidiabetikum

Country Status (13)

Country Link
US (1) US20040044043A1 (de)
EP (1) EP1315724B1 (de)
JP (1) JP2004508370A (de)
KR (1) KR100769008B1 (de)
CN (1) CN1239501C (de)
AT (1) ATE310000T1 (de)
AU (1) AU2001284285A1 (de)
CY (1) CY1105354T1 (de)
DE (1) DE60115062T2 (de)
DK (1) DK1315724T3 (de)
ES (1) ES2248385T3 (de)
GB (1) GB0021784D0 (de)
WO (1) WO2002020520A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
AU2002343050A1 (en) * 2001-11-21 2003-06-10 Smithkline Beecham P.L.C. 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
CN101511429A (zh) * 2006-07-13 2009-08-19 史密丝克莱恩比彻姆公司 二氢吲哚衍生物和gpr119激动剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
WO2002020520A1 (en) 2002-03-14
HK1057751A1 (en) 2004-04-16
KR20030027112A (ko) 2003-04-03
ES2248385T3 (es) 2006-03-16
EP1315724B1 (de) 2005-11-16
DE60115062D1 (de) 2005-12-22
JP2004508370A (ja) 2004-03-18
CN1471529A (zh) 2004-01-28
DE60115062T2 (de) 2006-06-29
CN1239501C (zh) 2006-02-01
EP1315724A1 (de) 2003-06-04
AU2001284285A1 (en) 2002-03-22
DK1315724T3 (da) 2006-02-20
GB0021784D0 (en) 2000-10-18
US20040044043A1 (en) 2004-03-04
CY1105354T1 (el) 2010-03-03
KR100769008B1 (ko) 2007-10-22

Similar Documents

Publication Publication Date Title
ATE310000T1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
ATE329914T1 (de) Rosiglitazon-edisylate und ihre verwendung als antidiabetika
ATE343574T1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
NZ515166A (en) Thiazolidinedione derivative and its use as antidiabetic
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
DK1349855T3 (da) 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt
AP1680A (en) Thiazolidinedione derivative and its use as antidiabetic.
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
CY1107767T1 (el) Παραγωγο θειαζολιδινοδιονης και χρηση αυτου σαν αντιδιαβητικο
DE60217168D1 (de) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dion-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff
ECSP003434A (es) Nuevos compuestos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1315724

Country of ref document: EP

REN Ceased due to non-payment of the annual fee